Valproic acid treatment after experimental subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 120, Issue , 2015, Pages 81-85

  Tso, Michael K ^a,b   Lass, Elliot ^a   Ai, Jinglu ^a   Loch Macdonald, R ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain injury; Mouse; Neuroprotection; Prechiasmatic injection model; Subarachnoid hemorrhage; Valproic acid

Indexed keywords

CASPASE 3; EOSIN; HEMATOXYLIN; NEURON SPECIFIC NUCLEAR PROTEIN; VALPROIC ACID; ANTICONVULSIVE AGENT; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASSESSMENT OF HUMANS; BEHAVIOR ASSESSMENT; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN INJURY ASSESSMENT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY; MODIFIED GARCIA SCORE; MORTALITY; MOUSE; MOUSE MODEL; NEUROPROTECTION; NONHUMAN; SUBARACHNOID HEMORRHAGE; TREND STUDY; VASOSPASM; ANIMAL; BRAIN CIRCULATION; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; VASOSPASM, INTRACRANIAL;

ANIMALS; ANTICONVULSANTS; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; MALE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; SUBARACHNOID HEMORRHAGE; VALPROIC ACID; VASOSPASM, INTRACRANIAL;

EID: 84921654145     PISSN: 00651419     EISSN: 21978395     Source Type: Book Series    
DOI: 10.1007/978-3-319-04981-6_14     Document Type: Article

References (10)

1. Chateauvieux S, Morceau F, Dicato M, Diederich M (2010) Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol. doi: 10. 1155/2010/479364.
2. Dash PK, Orsi SA, Zhang M, Grill RJ, Pati S, Zhao J, Moore AN (2010) Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One. doi: 10. 1371/journal. pone. 0011383.
3. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31: 1443-1451.
4. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321: 892-901.
5. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebocontrolled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10: 618-625.
6. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM (2004) Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89: 1358-1367.
7. Rinkel GJ, Algra A (2011) Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 10: 349-356.
8. Sabri M, Jeon H, Ai J, Tariq A, Shang X, Chen G, Macdonald RL (2009) Anterior circulation mouse model of subarachnoid hemorrhage. Brain Res 1295: 179-185.
9. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874: 123-130.
10. Sherchan P, Lekic T, Suzuki H, Hasegawa Y, Rolland W, Duris K, Zhan Y, Tang J, Zhang JH (2011) Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats. J Neurotrauma 28: 2503-2512.